Shares of NanoString Technologies, Inc. (NASDAQ:NSTG – Get Free Report) have received an average recommendation of “Hold” from the six analysts that are presently covering the company, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $7.63.
Separately, StockNews.com started coverage on NanoString Technologies in a research report on Wednesday. They issued a “sell” rating on the stock.
Check Out Our Latest Research Report on NanoString Technologies
NanoString Technologies Price Performance
Institutional Trading of NanoString Technologies
Several institutional investors and hedge funds have recently made changes to their positions in NSTG. Guggenheim Capital LLC grew its position in NanoString Technologies by 3.5% in the first quarter. Guggenheim Capital LLC now owns 19,410 shares of the biotechnology company’s stock worth $675,000 after acquiring an additional 659 shares in the last quarter. LPL Financial LLC boosted its holdings in shares of NanoString Technologies by 3.9% in the 2nd quarter. LPL Financial LLC now owns 20,563 shares of the biotechnology company’s stock worth $261,000 after purchasing an additional 779 shares in the last quarter. Advisor Group Holdings Inc. increased its position in shares of NanoString Technologies by 21.1% during the 1st quarter. Advisor Group Holdings Inc. now owns 4,595 shares of the biotechnology company’s stock valued at $162,000 after purchasing an additional 800 shares during the last quarter. First Republic Investment Management Inc. raised its holdings in shares of NanoString Technologies by 4.4% during the 2nd quarter. First Republic Investment Management Inc. now owns 22,393 shares of the biotechnology company’s stock valued at $284,000 after buying an additional 953 shares in the last quarter. Finally, Clearbridge Investments LLC lifted its position in NanoString Technologies by 0.5% in the 1st quarter. Clearbridge Investments LLC now owns 227,288 shares of the biotechnology company’s stock worth $7,898,000 after buying an additional 1,033 shares during the last quarter.
NanoString Technologies Company Profile
NanoString Technologies, Inc develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system.
See Also
- Five stocks we like better than NanoString Technologies
- Business Services Stocks Investing
- United Airlines Soars on Earnings Beat
- Investing In Automotive Stocks
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Investing in large cap stocks: Diving into big caps
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.